PiramalGlass
| Public | |
| Traded as | : PIRGLASS, : (BSE SENSEX Constituent) |
| Industry | Containers & Packaging |
| Founded | 1984 |
| Headquarters | Mumbai, Maharashtra, India |
|
Area served
|
Worldwide |
|
Key people
|
Ajay Piramal (Chairman) Vijay Shah (Managing Director) |
| Products | Cosmetics and Perfumery, Pharmaceuticals, Specialty Food and Bevarages, Decorations |
| Parent | Piramal Group |
| Website | glass |
Piramal Glass Limited (: PIRGLASS, : ) (formerly known as Gujarat Glass Pvt Ltd) is an Indian glass packaging company providing packaging for Pharmaceutical and Perfume Industry. Prior to acquisition in 1984 by Piramal Group, the company located its manufacturing plant in Kosamba, Gujarat. In 1990 Gujarat Glass Pvt Ltd merged with its parent company Nicholas Piramal India Ltd to become one of its many divisions.
Piramal Glass flogs glass packaging for the pharmaceuticals, foods & beverages (F&B) and cosmetics & perfumery (C&P) industries, services, listed at both (BSE: 532949) and (NSE: PIRGLASS).
Piramal Glass offers full bottle design capabilities, in-house mould design, CNC machines for mould manufacturing, glass manufacturing and dedicated ancillaries for decoration and accessories like caps, cartons and brushes.
Piramal Glass is the second largest manufacturer of flacconage glass for the cosmetic and perfumery (C&P) businesses with a capacity of 545 TPD. It currently has ~ 6% of the USD 2.3 bn global market share. The segment caters to customers across 44 countries including L’Oreal, Yves Rocher, LVMH, Coty, Bogart, Elizabeth Arden, Estee Lauder. C&P as a business segment contributed 51% of the consolidated sales in FY2012.
C&P business is further segmented as Color Cosmetics, Low Mass Perfumes, MNC Mass Perfumes, Select Perfumes. Within the Color cosmetics (Nail Polish) segment, Piramal Glass claims to be the world leader with a 50% market share. The Premium business of C&P, which includes the Select and MNC Mass segment, is the prime focus of Piramal Glass’s growth strategy. Piramal Glass claims to be the fastest growing player in C&P business with a CAGR of 18.4% over the last 5 years.
Piramal Glass has a 35% share of India’s USD 111 million market opportunity with a client roster that includes Cipla, PHL, Abbott, Pfizer, GlaxoSmithKline, Alembic, Merck, Ranbaxy, Strides Arcolab, Hospira amongst others.
This segment contributed 23% of the consolidated sales in FY2012. The Amber and Flint bottles and vials for liquid oral formulations, injectables etc. produced conform to the US, Indian and European pharmacopeia in Type I, Type II and Type III Glass.
...
Wikipedia